We are live on
!
Find out more
BCM
Brookmont Capital Management Portfolio holdings
AUM
$186M
1-Year Est. Return
10.11%
This Fund
S&P 500
This Quarter
Est. Return
+6.13%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$165M
AUM Growth
+$10.1M
(+6.5%)
Cap. Flow
+$1.03M
Cap. Flow
% of AUM
0.62%
Top 10 Holdings %
Top 10 Hldgs %
55.04%
Holding
57
New
4
Increased
28
Reduced
21
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$1.38M |
| 2 |
Honeywell
HON
|
+$1.13M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$214K |
| 4 |
Vanguard Intermediate-Term Bond ETF
BIV
|
+$204K |
| 5 |
NVIDIA
NVDA
|
+$199K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$2.15M |
| 2 |
Lowe's Companies
LOW
|
+$215K |
| 3 |
Wells Fargo
WFC
|
+$25K |
| 4 |
JPMorgan Chase
JPM
|
+$22.6K |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$20.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 35.14% |
| 2 | Financials | 13.2% |
| 3 | Healthcare | 9.31% |
| 4 | Technology | 8.92% |
| 5 | Industrials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Diageo
DEO
$51.7B
| $2.51M | 1.52% |
13,091
+15
| +0.1% | +$2.79K |
|
27
Johnson & Johnson
JNJ
$620B
| $2.51M | 1.52% |
15,232
-10
| -0.1% | -$1.66K |
|
|
RDS.B
28
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $2.43M | 1.47% |
62,582
+156
| +0.2% | +$5.88K |
|
29
ConocoPhillips
COP
$142B
| $2.25M | 1.36% |
36,942
-84
| -0.2% | -$4.68K |
|
30
Gilead Sciences
GILD
$163B
| $1.84M | 1.11% |
26,664
+18
| +0.1% | +$1.2K |
|
31
RTX Corp
RTX
$301B
| $1.45M | 0.88% |
17,032
+14
| +0.1% | +$1.18K |
|
32
iShares Core S&P 500 ETF
IVV
$897B
| $1.36M | 0.82% |
3,166
+100
| +3% | +$41.9K |
|
33
Sonoco
SON
$5.65B
| $1.31M | 0.79% |
19,544
-27
| -0.1% | -$1.79K |
|
34
Unilever
UL
$137B
| $1.29M | 0.78% |
19,606
-11
| -0.1% | -$731 |
|
35
Evergy
EVRG
$19.2B
| $1.16M | 0.7% |
19,247
+32
| +0.2% | +$2K |
|
36
iShares Russell 1000 Growth ETF
IWF
$127B
| $1.08M | 0.65% |
15,856
+148
| +0.9% | +$9.54K |
|
37
Tyson Foods
TSN
$20.6B
| $1.08M | 0.65% |
14,582
-91
| -0.6% | -$7.06K |
|
38
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $989K | 0.6% |
18,405
+320
| +2% | +$17.3K |
|
39
iShares Core S&P Small-Cap ETF
IJR
$112B
| $968K | 0.59% |
8,567
+98
| +1% | +$10.9K |
|
40
iShares MSCI EAFE ETF
EFA
$79.4B
| $873K | 0.53% |
11,072
+259
| +2% | +$20.6K |
|
41
Vanguard Dividend Appreciation ETF
VIG
$114B
| $723K | 0.44% |
4,672
+112
| +2% | +$17.2K |
|
42
Vanguard Morningstar Total Stock Market ETF
VTI
$680B
| $619K | 0.37% |
2,780
| – | – |
|
43
Walt Disney
DIS
$181B
| $577K | 0.35% |
3,285
-66
| -2% | -$11.9K |
|
44
iShares Core US Aggregate Bond ETF
AGG
$137B
| $576K | 0.35% |
4,996
+391
| +8% | +$44.8K |
|
45
Stryker
SYK
$129B
| $341K | 0.21% |
1,314
-74
| -5% | -$18.9K |
|
46
ExxonMobil
XOM
$640B
| $294K | 0.18% |
4,664
-117
| -2% | -$6.99K |
|
47
Starbucks
SBUX
$120B
| $290K | 0.18% |
2,595
-78
| -3% | -$8.82K |
|
|
48
NVIDIA
NVDA
$5.32T
| $249K | 0.15% |
+12,440
| New | +$199K |
|
49
State Street SPDR S&P 500 ETF Trust
SPY
$818B
| $246K | 0.15% |
575
-15
| -3% | -$6.26K |
|
50
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $218K | 0.13% |
4,008
+158
| +4% | +$8.41K |
|
Similar funds
CC
BGA
OBC
LPCM
HC
WWM
RCM
BAM
Brookmont Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Brookmont Capital Management held 57 positions worth $165M, up 6.5% from $155M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Brookmont Capital Management's Q2 2021 filing shows 4 new, 28 increased, 21 reduced and 2 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 2,600 shares worth $214K. The largest sale was Novartis, an estimated $2.15M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- Brookmont Capital Management's largest Q2 2021 buy was Vanguard Short-Term Bond ETF: 2,600 shares worth $214K.
- Brookmont Capital Management added most to Paramount Global Class B in Q2 2021, an estimated $1.38M increase.
- Brookmont Capital Management's biggest Q2 2021 reduction was Wells Fargo, cutting an estimated $25K.
- Brookmont Capital Management fully exited Novartis in Q2 2021, selling an estimated $2.15M.
- Brookmont Capital Management's ten largest holdings make up 55% of its $165M portfolio in Q2 2021.
- Brookmont Capital Management opened 4 new positions and closed 2 in Q2 2021.
- Brookmont Capital Management's portfolio value rose 6.5% quarter-over-quarter to $165M.
Based on Brookmont Capital Management's 13F filing for Q2 2021, filed 19 Jul 2021.